NCT06556589 Collaborative Care for Treatment of Depression and Anxiety
| NCT ID | NCT06556589 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kaiser Permanente |
| Condition | Depression |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2023-03-01 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2023-03-01 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this project is to evaluate the effectiveness of a collaborative care model for primary care patients at Kaiser Permanente Colorado (KPCO) with depression and/or anxiety. Collaborative care uses evidence-based short-term treatments delivered to patients over the phone. We will explore the use of cost-efficient automated processes for patient outreach and follow-up, such as care pools of patients and using patient portal messaging, risk-based results routing to providers, and electronic health record (EHR) tools for patient tracking and outcome assessment. Using a cluster randomized design, we will compare results between clinics that are offering collaborative care to those that are not.
Eligibility Criteria
Inclusion Criteria: * 18+ * Current membership and active on patient portal * Depression Diagnosis in the prior year * Overdue for PHQ9 Screening based on the following criteria: * High Risk: Last PHQ9 screener was completed greater than 4 months ago AND total Score is greater than or equal 10 or item 9 is greater than 0. * Low Risk: Last PHQ9 screener was completed greater than 12 months ago AND Last PHQ9 Total Score is less than 10 and item 9 is equal to 0. * Anxiety diagnoses in the prior year * Has a baseline GAD7 in the same prior year; score = 10+ (\*Note: Provider referrals could be GAD7 score of 7 or higher) * No Behavioral Health (BH) engagement in the prior year * Patient is not in a Skilled Nursing Facility or Hospice * Patient has no record of psychiatric hospitalization in the last year * Patient does not need an interpreter (i.e., English speaking) * Primary care location is one of the intervention clinics Exclusion Criteria: • Exclude individuals with any of the following diagnoses: * Psychosis * Dementia * Bipolar * Personality Disorders * Post Traumatic Stress Disorder (PTSD) * Obsessive Compulsive Disorder (OCD) * Panic Disorder * Cognitive Disorder
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06556589 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06556589 currently recruiting?
Yes, NCT06556589 is actively recruiting participants. Contact the research team at Arne.Beck@kp.org for enrollment information.
Where is the NCT06556589 trial being conducted?
This trial is being conducted at Aurora, United States.
Who is sponsoring the NCT06556589 clinical trial?
NCT06556589 is sponsored by Kaiser Permanente. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.